Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Wedbush upped their Q2 2024 earnings estimates for Sage Therapeutics in a note issued to investors on Thursday, April 25th. Wedbush analyst L. Chico now anticipates that the biopharmaceutical company will post earnings of ($1.83) per share for the quarter, up from their prior forecast of ($2.00). […]
Mizuho Lowers Sage Therapeutics (NASDAQ:SAGE) Price Target to $18 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Sage Therapeutics (NASDAQ:SAGE – Free Report) had its target price cut by Royal Bank of Canada from $26.00 to $15.00 in a report released on Friday morning, Benzinga reports. They currently have a sector perform rating on the biopharmaceutical company’s stock. Other equities research analysts have also issued reports about the stock. Oppenheimer reduced their […]
StockWatch: Biogen Q1 Results Beat Expectations, for a Change genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its target price decreased by research analysts at Mizuho from $20.00 to $18.00 in a report issued on Friday, Benzinga reports. The brokerage presently has a “neutral” rating on the biopharmaceutical company’s stock. Mizuho’s price target indicates a potential upside of 31.48% from the stock’s current price. […]